BONETTI, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 5.484
EU - Europa 5.389
AS - Asia 2.878
SA - Sud America 346
Continente sconosciuto - Info sul continente non disponibili 141
AF - Africa 111
OC - Oceania 12
Totale 14.361
Nazione #
US - Stati Uniti d'America 5.170
RU - Federazione Russa 1.315
CN - Cina 968
IT - Italia 790
IE - Irlanda 789
SG - Singapore 730
GB - Regno Unito 585
FI - Finlandia 544
UA - Ucraina 431
VN - Vietnam 368
BR - Brasile 258
DE - Germania 241
CA - Canada 230
HK - Hong Kong 217
SE - Svezia 213
FR - Francia 183
TR - Turchia 156
BD - Bangladesh 76
BG - Bulgaria 70
KR - Corea 66
IN - India 58
MX - Messico 52
ZA - Sudafrica 50
PL - Polonia 38
IL - Israele 35
IQ - Iraq 35
JP - Giappone 34
ES - Italia 29
CZ - Repubblica Ceca 26
ID - Indonesia 26
NL - Olanda 23
AR - Argentina 22
PK - Pakistan 21
BE - Belgio 19
CL - Cile 16
TN - Tunisia 16
CH - Svizzera 15
DK - Danimarca 15
CO - Colombia 13
SA - Arabia Saudita 13
EC - Ecuador 12
AU - Australia 10
EU - Europa 10
PH - Filippine 10
EG - Egitto 9
VE - Venezuela 9
AT - Austria 8
JO - Giordania 8
LT - Lituania 8
TH - Thailandia 8
RO - Romania 7
UZ - Uzbekistan 7
CR - Costa Rica 6
JM - Giamaica 6
KE - Kenya 6
MA - Marocco 6
MY - Malesia 6
PT - Portogallo 6
AL - Albania 5
ET - Etiopia 5
GR - Grecia 5
HU - Ungheria 5
PE - Perù 5
BY - Bielorussia 4
GT - Guatemala 4
HN - Honduras 4
KG - Kirghizistan 4
LK - Sri Lanka 4
NP - Nepal 4
PY - Paraguay 4
SV - El Salvador 4
AZ - Azerbaigian 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
KW - Kuwait 3
LV - Lettonia 3
NO - Norvegia 3
OM - Oman 3
SC - Seychelles 3
SY - Repubblica araba siriana 3
TW - Taiwan 3
UY - Uruguay 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
CI - Costa d'Avorio 2
DZ - Algeria 2
HR - Croazia 2
IR - Iran 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BF - Burkina Faso 1
BJ - Benin 1
BS - Bahamas 1
BZ - Belize 1
Totale 14.217
Città #
Dublin 789
Ashburn 709
San Jose 585
Helsinki 476
Singapore 393
Chandler 378
Southend 373
Jacksonville 346
Hefei 331
Dallas 277
Moscow 260
Ann Arbor 226
Council Bluffs 226
Milan 213
Hong Kong 203
Beijing 191
Toronto 177
Dearborn 171
Dong Ket 135
Salerno 130
New York 122
Wilmington 92
Edison 82
Boston 80
Columbus 80
Lawrence 76
Ho Chi Minh City 72
Lauterbourg 72
Los Angeles 71
Izmir 69
Seoul 66
Woodbridge 63
Hanoi 59
Boardman 52
Houston 47
Rome 47
Johannesburg 46
Seattle 46
Modena 44
Redwood City 44
Mountain View 43
Santa Clara 39
Fremont 37
São Paulo 37
Nanjing 34
Fairfield 32
Tel Aviv 32
The Dalles 31
Tokyo 28
Warsaw 28
Kunming 24
Mexico City 22
Falls Church 21
Frankfurt am Main 21
Orem 20
Jakarta 18
Montreal 18
Phoenix 18
Chennai 16
Atlanta 15
Brussels 15
Denver 15
London 15
Ottawa 15
Da Nang 14
Jinan 14
Nuremberg 14
Amsterdam 13
Bologna 13
Dhaka 13
Haymarket 13
Munich 13
Stockholm 13
Guangzhou 12
Chicago 11
Dammarie 11
Shanghai 11
Assago 10
Auburn Hills 10
Brooklyn 10
San Francisco 10
Chengdu 9
Mumbai 9
Norwalk 9
Wuhan 9
Amman 8
Buffalo 8
Nanchang 8
Paris 8
Santiago 8
Torino 8
Bangkok 7
Erbil 7
Falkenstein 7
Genoa 7
Istanbul 7
Poplar 7
Washington 7
Cairo 6
Cambridge 6
Totale 8.863
Nome #
Pandemics and socio-economic status : evidence from the plague of 1630 in Northern Italy 434
A survival analysis of the last great European plagues: the case of Nonantola (Northern Italy) in 1630 433
GiniInc: a Stata package for measuring inequality from incomplete income and survival data 378
Neurocognitive assessment in obsessive compulsive disorder patients: adherence to behavioral decision models 318
An analysis of the number of medical malpractice claims and their amounts 305
The Gini concentration index for the study of survival 288
Clustering-based measurement of dependence 260
A proposal for a two-step sampling design to oversample units responding to prescribed characteristics 229
A bivariate method for spatio-temporal syndromic surveillance 227
Longevity and concentration in survival times: the log-scale-location family of failure time models 226
The Gini Test for Survival Data in Presence of Small and Unbalanced Groups. 218
Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: A randomized trial 212
A method-of-moments estimation procedure for categorical quality-of-life data with nonignorable missingness 210
A bivariate method for spatio-temporal syndromic surveillance (article published in proceedings) 207
A graphical method to assess treatment-covariate interactions using the Cox model on subsets of the data 207
Effect of the number of removed lymph nodes on prostate cancer recurrence and survival: evidence from an observational study 207
A multistate Markov chain model for longitudinal, categorical quality-of-life data subject to non-ignorable missingness 202
A population-adjusted stable geospatial baseline for outbreak detection in syndromic surveillance (poster with abstract published in proceedings) 200
Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: Results of the Italian randomized cooperative trial 198
Biomarkers, subgroup evaluation, and clinical trial design 198
Another STEPP in the right direction 197
Asymptotic behavior of a set-statistic 196
CEF is superior to CMF for tumours with TOP2A aberrations: A Subpopulation Treatment Effect Pattern Plot (STEPP) analysis on Danish Breast Cancer Cooperative Group Study 89D. 192
A permutation test for determining significance of clusters with applications to spatial and gene expression data 191
A new geometric approach to data analysis using the Minkowski polytope 190
Approximate Bayesian computation for the natural history of breast cancer, with application to data from a Milan cohort study 189
The Gini concentration test for survival data 188
A nonparametric scoring algorithm for identifying informative genes from microarray data 187
COVID-19 vaccine concerns about safety, effectiveness, and policies in the United States, Canada, Sweden, and Italy among unvaccinated individuals 186
A note on the length-biased Weibull-Gamma frailty survival model 180
Marshall–Olkin frailty survival models for bivariate right-censored failure time data 180
Parametric and nonparametric analysis of life courses: an application to family formation patterns 174
Cardiac safety of trastuzumab (H) in combination with pegylated liposomal doxorubicin (D) and docetaxel (T) in HER2-positive metastatic breast cancer (MBC): preliminary results of the Eastern Cooperative Oncology Group Trial E3198 (Abstract) 171
A small sample study of the STEPP approach to assessing treatment–covariate interactions in survival data. 171
Freedom of choice to vaccinate and COVID-19 vaccine hesitancy in Italy 167
Meta-STEPP: subpopulation treatment effect pattern plot for individual patient data meta-analysis 167
Parametric modelling of interpoint distance distributions, with an application to a mixture model for biosurveillance data 165
M statistic commands: interpoint distance distribution analysis. 164
Linking excess mortality to mobility data during the first wave of COVID-19 in England and Wales 164
Exploring the association between misinformation endorsement, opinions on the government response, risk perception, and COVID-19 vaccine hesitancy in the US, Canada, and Italy 159
Tailoring adjuvant treatments for the individual breast cancer patient 159
Meta-STEPP with random effects 159
The Gini Concentration Test for Survival Data 159
Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: The International Breast Cancer Study Group Trial VII 157
Patterns of treatment effects in subsets of patients in clinical trials 157
Duration of adjuvant chemotherapy for breast cancer: A joint analysis of two randomised trials investigating three versus six courses of CMF 155
Risk factors for locoregional recurrence among breast cancer patients: Results from international breast cancer study group trials I through VII 153
Computing the exact distributions of some functions of the ordered multinomial counts: maximum, minimum, range and sums of order statistics 153
Real time spatial cluster detection using interpoint distances among precise patient locations 150
Lorenz Curves and Treatment-Covariate Interactions in Clinical Trials 150
Prognostic Value of Extracapsular Tumor Spread for Locoregional Control in Premenopausal Patients With Node-Positive Breast Cancer Treated With Classical Cyclophosphamide, Methotrexate, and Fluorouracil: Long-Term Observations From International Breast Cancer Study Group Trial VI 148
Cross-national vaccine concerns and predictors of vaccine hesitancy in not-fully vaccinated individuals: findings from USA, Canada, Sweden, and Italy 145
Interpoint distance distribution 144
Modelling menstrual status during and after adjuvant treatment for breast cancer 142
Evaluating markers for guiding treatment 140
MAX2 - A convenient index to estimate the average per patient risk for chemotherapy toxicity: Validation in ECOG trials 139
The interpoint distance distribution as a descriptor of point patterns, with an application to cluster detection 138
The choice of the number of bins for the M statistic 138
Identifying treatment effect heterogeneity in clinical trials using subpopulations of events: STEPP 137
Subpopulation Treatment Effect Pattern Plot (STEPP) analysis for continuous, binary, and count outcomes 136
Evaluation of Treatment-Effect Heterogeneity Using Biomarkers Measured on a Continuous Scale: Subpopulation Treatment-Effect Pattern Plot (STEPP). 134
Discussion of the Frangakis and Rubin article 133
MAX2: a convenient index to estimate the average per patient risk of severe toxicity from a chemotherapy regimen. Testing in ECOG studies (Abstract) 129
The distribution of interpoint distances 128
Identifying breast cancer patients at high risk for bone metastases 128
Early Start of Adjuvant Chemotherapy May Improve Treatment Outcome for Premenopausal Breast Cancer Patients With Tumors not Expressing Estrogen Receptors 128
Deformable templates: a statistical setting 126
Power comparisons for an improved disease clustering test 126
Effect of glutathione S-transferase polymorphisms and proximity to hazardous waste sites on time to systemic lupus erythematosus diagnosis results from the Roxbury Lupus Project 125
Enhanced power to detect bioterrorism with spatial clustering (abstract) 124
Distance-based methods for spatial and spatio-temporal surveillance 124
Evaluation of age-specific causes of death in the context of the Italian longevity transition 123
Principles of clinical trials 121
Parametric models for interpoint distances and their use in biosurveillance 120
Endocrine Responsiveness and Tailoring Adjuvant Therapy for Postmenopausal Lymph Node-Negative Breast Cancer: A Randomized Trial 119
Invited review of article: Jiang, Runchao; Lu, Wenbin; Song, Rui; Davidian, Marie (2017). On estimation of optimal treatment regimes for maximizing t-year survival probability. R. Stat. Soc. Ser. B. Stat. Methodol. 79 (2017), no. 4, 1165–1185. 118
Epilocal: a real-time tool for local epidemic monitoring 118
Features that predict responsiveness to chemotherapy and endocrine therapies 114
Subpopulation Treatment Effect Pattern Plot (STEPP) methods with R and Stata 111
The sparsity index in Poisson size-biased sampling: algorithms for the optimal unbiased estimation from small samples 111
The use of multiple addresses to enhance cluster detection 110
The average uneven mortality index: building on the "e-dagger" measure of lifespan inequality 97
Totale 14.361
Categoria #
all - tutte 58.254
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.254


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022471 0 0 12 18 32 38 35 71 56 55 84 70
2022/20231.861 85 44 35 119 143 117 60 110 991 29 77 51
2023/2024911 48 41 56 13 109 119 77 103 41 39 119 146
2024/20251.307 34 33 58 26 63 40 178 71 442 126 129 107
2025/20265.527 338 564 175 355 405 235 732 579 1.395 550 151 48
2026/2027502 247 234 21 0 0 0 0 0 0 0 0 0
Totale 14.361